Literature DB >> 30467188

Tfr2 suppression benefits β-thalassemic erythropoiesis.

Yelena Z Ginzburg1, Robert E Fleming2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30467188      PMCID： PMC6251007          DOI： 10.1182/blood-2018-10-876110

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.

Authors:  Sara Gardenghi; Pedro Ramos; Maria Franca Marongiu; Luca Melchiori; Laura Breda; Ella Guy; Kristen Muirhead; Niva Rao; Cindy N Roy; Nancy C Andrews; Elizabeta Nemeth; Antonia Follenzi; Xiuli An; Narla Mohandas; Yelena Ginzburg; Eliezer A Rachmilewitz; Patricia J Giardina; Robert W Grady; Stefano Rivella
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

2.  Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia.

Authors:  Gautam Rishi; Eriza S Secondes; Daniel F Wallace; V Nathan Subramaniam
Journal:  Am J Hematol       Date:  2016-06-12       Impact factor: 10.047

3.  A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction.

Authors:  Daniel F Wallace; Eriza S Secondes; Gautam Rishi; Lesa Ostini; Cameron J McDonald; Steven W Lane; Therese Vu; John D Hooper; Gloria Velasco; Andrew J Ramsay; Carlos Lopez-Otin; V Nathan Subramaniam
Journal:  Br J Haematol       Date:  2014-11-17       Impact factor: 6.998

4.  Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera.

Authors:  Carla Casu; Paraskevi Rea Oikonomidou; Huiyong Chen; Vijay Nandi; Yelena Ginzburg; Princy Prasad; Robert E Fleming; Yatrik M Shah; Erika V Valore; Elizabeta Nemeth; Tomas Ganz; Brian MacDonald; Stefano Rivella
Journal:  Blood       Date:  2016-05-06       Impact factor: 22.113

5.  Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis.

Authors:  Hana Forejtnikovà; Maud Vieillevoye; Yael Zermati; Mireille Lambert; Rosa Maria Pellegrino; Soizic Guihard; Muriel Gaudry; Clara Camaschella; Catherine Lacombe; Antonella Roetto; Patrick Mayeux; Frédérique Verdier
Journal:  Blood       Date:  2010-09-08       Impact factor: 22.113

6.  Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model.

Authors:  Irene Artuso; Maria Rosa Lidonnici; Sandro Altamura; Giacomo Mandelli; Mariateresa Pettinato; Martina U Muckenthaler; Laura Silvestri; Giuliana Ferrari; Clara Camaschella; Antonella Nai
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

7.  The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22.

Authors:  C Camaschella; A Roetto; A Calì; M De Gobbi; G Garozzo; M Carella; N Majorano; A Totaro; P Gasparini
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

8.  Hepcidin is decreased in TFR2 hemochromatosis.

Authors:  Elizabeta Nemeth; Antonella Roetto; Giovanni Garozzo; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

9.  The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.

Authors:  Antonella Nai; Rosa M Pellegrino; Marco Rausa; Alessia Pagani; Martina Boero; Laura Silvestri; Giuseppe Saglio; Antonella Roetto; Clara Camaschella
Journal:  Haematologica       Date:  2014-03-21       Impact factor: 9.941

10.  The second transferrin receptor regulates red blood cell production in mice.

Authors:  Antonella Nai; Maria Rosa Lidonnici; Marco Rausa; Giacomo Mandelli; Alessia Pagani; Laura Silvestri; Giuliana Ferrari; Clara Camaschella
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113
  10 in total
  1 in total

Review 1.  Transferrin Receptors in Erythropoiesis.

Authors:  Cyrielle Richard; Frédérique Verdier
Journal:  Int J Mol Sci       Date:  2020-12-19       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.